Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt, and forkhead signaling

Endocrinology

Volumn 152, Issue 2, 2011, Pages 503-514

  Poulsen, Raewyn C ^a   Carr, Andrew J ^a,b   Hulley, Philippa A ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Biomedical Research Unit ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; COLLAGEN TYPE 1; DEXAMETHASONE; GROWTH FACTOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TEMPOL; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1;

ADULT; ARTICLE; CELL; CELL COUNT; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TENDINITIS; TENOCYTE; UPREGULATION;

ADULT; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASCORBIC ACID; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DEXAMETHASONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOIDS; GLYCOSAMINOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 79951596650     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1087     Document Type: Article

References (48)

1. Stahn C, Buttgereit F 2008 Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 4:525-533
2. Garbe E, LeLorier J, Boivin JF, Suissa S 1997 Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 277:722-727 (Pubitemid 27106224)
3. Oikarinen A, Autio P 1991 New aspects of the mechanism of corticosteroid-induced dermal atrophy. Clin Exp Dermatol 16:416-419
4. Butler RC, Davie MW, Worsfold M, Sharp CA 1991 Bone-mineral content in patients with rheumatoid-arthritis: relationship to lowdose steroid-therapy. Br J Rheumatol 30:86-90
5. Dávila D, Torres-Aleman I 2008 Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol Biol Cell 19:2014-2025
6. Scutt N, Rolf CG, Scutt A 2006 Glucocorticoids inhibit tenocyte proliferation and tendon progenitor cell recruitment. J Orthop Res 24:173-182 (Pubitemid 43773028)
7. Wong MW, Lui WT, Fu SC, Lee KM 2009 The effect of glucocorticoids on tendon cell viability in human tendon explants. Acta Orthop 80:363-367
8. Wong MW, Tang YN, Lee SM, Fu BC, Chan BP, Chan CM 2003 Effect of dexamethasone on cultured human tenocytes and its reversibility by platelet-derived growth factor. J Bone Joint Surg 85A:1914-1920 (Pubitemid 37259726)
9. Torricelli P, Fini M, Giavaresi G, Carpi A, Nicolini A, Giardino R 2006 Effects of systemic glucocorticoid administration on tenocytes. Biomed Pharmacother 60:380-385 (Pubitemid 44428092)
10. Mikolyzk DK, Wei AS, Tonino P, Marra G, Williams DA, Himes RD, Wezeman FH, Callaci JJ 2009 Effect of corticosteroids on the biomechanical strength of rat rotator cuff tendon. J Bone Joint Surg Am 91:1172-1180
11. Ford LT, DeBender J 1979 Tendon-rupture after local steroid injection. South Med J 72:827-830
12. Nichols AW 2005 Complications associated with the use of corticosteroids in the treatment of athletic injuries. Clin J Sport Med 15:370-375 (Pubitemid 41376962)
13. Watson M 1985 Major ruptures of the rotator cuff. The results of surgical repair in 89 patients. J Bone Joint Surg Br 67:618-624 (Pubitemid 16228153)
14. Vegiopoulos A, Herzig S 2007 Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 275:43-61 (Pubitemid 47259280)
15. Fernandez-Rodriguez E, Stewart PM, Cooper MS 2009 The pituitary-adrenal axis and body composition. Pituitary 12:105-115
16. Schacke H, Berger M, Rehwinkel H, Asadullah K 2007 Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol Cell Endocrinol 275:109-117 (Pubitemid 47259282)
17. Haller J, Mikics E, Makara GB 2008 The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 29:273-291 (Pubitemid 351467120)
18. Silverman SL, Lane NE 2009 Glucocorticoid-induced osteoporosis. Curr Osteoporos Rep 7:23-26
19. Yao L, Bestwick CS, Bestwick LA, Maffulli N, Aspden RM 2006 Phenotypic drift in human tenocyte culture. Tissue Eng 12:1843-1849 (Pubitemid 44162843)
20. Espina B, Liang M, Russell G, Hulley PA 2006 Bim is a novel regulator of apoptosis in osteoblasts. Calcif Tissue Int 78:S31
21. Liang M, Russell G, Hulley PA 2008 Bim, Bak, and Bax regulate osteoblast survival. J Bone Miner Res 23:610-620 (Pubitemid 351575015)
22. Jacobs JW 2009 How to perform local soft-tissue glucocorticoid injections. Best Pract Res Clin Rheumatol 23:193-219
23. McIntosh LJ, Sapolsky RM 1996 Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 141:201-206 (Pubitemid 26338346)
24. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T 2003 Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92:81-87 (Pubitemid 36105610)
25. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M 1983 Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130:1910-1917 (Pubitemid 13091657)
26. Zöller NN, Kippenberger S, Thaçi D, Mewes K, Spiegel M, Sättler A, Schultz M, Bereiter-Hahn J, Kaufmann R, Bernd A 2008 Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicol in Vitro 22:747-759
27. Harvey W, Grahame R, Panayi GS 1974 Effects of steroid-hormones on human fibroblasts in vitro. 1. Glucocorticoid action on cell growth and collagen synthesis. Ann Rheum Dis 33:437-441
28. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412 (Pubitemid 38534545)
29. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL 2007 FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6:472-483 (Pubitemid 350163056)
30. Menconi M, Fareed M, O'Neal P, Poylin V, Wei W, Hasselgren PO 2007 Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35:S602-S608 (Pubitemid 47312202)
31. Dodd SL, Gagnon BJ, Senf SM, Hain BA, Judge AR 2010 Rosmediated activation of NF-κB and Foxo during muscle disuse. Muscle Nerve 41:110-113
32. Accili D, Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426 (Pubitemid 38610228)
33. Almeida M, Ambrogini E, Martin-Millan M, Han L, Warren A, Shelton RS, Plotkin L, Bellido T, O'Brien CA, Jilka RL, Weinstein RS, Manolagas SC, Induction of oxidative stress and diversion of β-catenin from TCF- to FOXO-mediated transcription by glucocorticoids or TNFα in osteoblastic cells. 30th Annual Meeting of the American Society for Bone and Mineral Research, Montreal, Canada, 2008, pp S170-S170
34. Moutsatsou P, Psarra AM, Tsiapara A, Paraskevakou H, Davaris P, Sekeris CE 2001 Localization of the glucocorticoid receptor in rat brain mitochondria. Arch Biochem Biophys 386:69-78 (Pubitemid 32980178)
35. Tsiriyotis C, Spandidos DA, Sekeris CE 1997 The mitochondrion as a primary site of action of glucocorticoids: mitochondrial nucleotide sequences, showing similarity to hormone response elements, confer dexamethasone inducibility to chimaeric genes transfected in LATK(-) cells. Biochem Biophys Res Commun 235:349-354 (Pubitemid 27313709)
36. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS, Manji HK 2009 Dynamic regulation of mitochondrial function by glucocorticoids. Proc Nat Acad Sci 106:3543-3548
37. Parthasarathy S, Morales AJ, Murphy AA 1994 Antioxidant: a new role for RU-486 and related compounds. J Clin Invest 94:1990-1995 (Pubitemid 24348238)
38. Esposito F, Cuccovillo F, Morra F, Russo T, Cimino F 1995 DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells. Biochim Biophys Acta 1260:308-314
39. Hutchison KA, Matiæ G, Meshinchi S, Bresnick EH, Pratt WB 1991 Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. J Biol Chem 266:10505-10509
40. Makino Y, Okamoto K, Yoshikawa N, Aoshima M, Hirota K, Yodoi J, Umesono K, Makino I, Tanaka H 1996 Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 98:2469-2477 (Pubitemid 26415067)
41. Tanaka H, Makino Y, Okamoto K, Iida T, Yan K, Yoshikawa N 1999 Redox regulation of the glucocorticoid receptor. Antioxid Redox Signal 1:403-423 (Pubitemid 129628307)
42. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM 2002 Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:316-321
43. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, Fukamizu A 2005 Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Nat Acad Sci 102:11278-11283 (Pubitemid 41153811)
44. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857-868 (Pubitemid 29165088)
45. Essaghir A, Dif N, Marbehant CY, Coffer PJ, Demoulin JB 2009 The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. J Biol Chem 284:10334-10342
46. Plas DR, Thompson CB 2003 Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 278:12361-12366 (Pubitemid 36800220)
47. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y 2005 JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170:295-304 (Pubitemid 41043811)
48. Tanaka H, Okada T, Konishi H, Tsuji T 1993 The effect of reactive oxygen species on the biosynthesis of collagen and glycosaminoglycans in cultured human dermal fibroblasts. Arch Dermatol Res 285:352-355 (Pubitemid 23265517)